Delays to Low-risk Thyroid Cancer Treatment During COVID-19—Refocusing From What Has Been Lost to What May Be Learned and Gained

Field	Value	Language
dc.contributor.author	Nickel, Brooke	en
dc.contributor.author	Glover, Anthony	en
dc.contributor.author	Miller, Julie A.	en
dc.date.accessioned	2021-02-09T22:29:42Z
dc.date.available	2021-02-09T22:29:42Z
dc.date.issued	2021	en
dc.identifier.uri	https://hdl.handle.net/2123/24465
dc.description.abstract	This Viewpoint examines the potential benefits that delaying low-risk thyroid surgical procedures may provide for patients as the coronavirus disease 2019 pandemic continues to alter treatment timelines.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Delays to Low-risk Thyroid Cancer Treatment During COVID-19—Refocusing From What Has Been Lost to What May Be Learned and Gained	en
dc.type	Article	en
dc.identifier.doi	10.1001/jamaoto.2020.3878
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.